Document Detail


Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice.
MedLine Citation:
PMID:  6796268     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
N-Diazoacetyl derivatives of glycine and phenylalanine show antitumor activity in mice bearing P388 leukemia or B16 melanoma. The presented data indicate that antitumor activity is shown by diazomethylamide derivatives of glycine and phenylalanine, in addition to that already established for the amino acid derivatives having an O-diazoacetyl group (azaserine) or a diazoketone structure (DON and azotomycin) and for 1,2-bis-diazoacetyl ethane.
Authors:
G Sava; T Giraldi; L Baldini
Related Documents :
2077548 - Molluscicidal properties of constituents from the liverwort ricciocarpos natans and of ...
12026118 - Synthesis and tumoricidal activity evaluation of new morin and quercetin sulfonic deriv...
2764508 - Vinblastine-c4 alkyl maleoyl and amino acid maleoyl derivatives: i. chemistry and physi...
237008 - Affinity chromatography of beta-galactosidase on controlled-pore glass derivatives.
16556218 - A novel high-affinity arginine transporter from the human parasitic protozoan leishmani...
3920728 - Arachidonic acid metabolic pathway of the rabbit placenta.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer treatment reports     Volume:  66     ISSN:  0361-5960     ISO Abbreviation:  Cancer Treat Rep     Publication Date:  1982 Jan 
Date Detail:
Created Date:  1982-02-25     Completed Date:  1982-02-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7607107     Medline TA:  Cancer Treat Rep     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  179-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents*
Azo Compounds / therapeutic use*
Glycine / analogs & derivatives,  therapeutic use*
Leukemia, Experimental / drug therapy*
Melanoma / drug therapy*
Mice
Neoplasms, Experimental / drug therapy
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Azo Compounds; 56-40-6/Glycine; 820-75-7/N-diazoacetylglycine hydrazide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing m...
Next Document:  Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma...